These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1745432

  • 21. The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease.
    Stavitsky K, Brickman AM, Scarmeas N, Torgan RL, Tang MX, Albert M, Brandt J, Blacker D, Stern Y.
    Arch Neurol; 2006 Oct; 63(10):1450-6. PubMed ID: 17030662
    [Abstract] [Full Text] [Related]

  • 22. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
    Antal A, Bodis-Wollner I.
    Neurobiology (Bp); 1993 Oct; 1(2):101-22. PubMed ID: 8111350
    [Abstract] [Full Text] [Related]

  • 23. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW.
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [Abstract] [Full Text] [Related]

  • 24. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
    Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, Michel B, Puel M, Volteau M, Touchon J, Verny M, Dubois B.
    Neurology; 2007 Nov 06; 69(19):1859-67. PubMed ID: 17984454
    [Abstract] [Full Text] [Related]

  • 25. Animal cognition: defining the issues.
    Sarter M.
    Neurosci Biobehav Rev; 2004 Nov 06; 28(7):645-50. PubMed ID: 15555674
    [Abstract] [Full Text] [Related]

  • 26. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
    Rockenstein E, Crews L, Masliah E.
    Adv Drug Deliv Rev; 2007 Sep 30; 59(11):1093-102. PubMed ID: 17869376
    [Abstract] [Full Text] [Related]

  • 27. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec 30; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 28. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition.
    Leighty RE, Nilsson LN, Potter H, Costa DA, Low MA, Bales KR, Paul SM, Arendash GW.
    Behav Brain Res; 2004 Aug 12; 153(1):107-21. PubMed ID: 15219712
    [Abstract] [Full Text] [Related]

  • 29. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
    Ostrovskaya RU, Gruden MA, Bobkova NA, Sewell RD, Gudasheva TA, Samokhin AN, Seredinin SB, Noppe W, Sherstnev VV, Morozova-Roche LA.
    J Psychopharmacol; 2007 Aug 12; 21(6):611-9. PubMed ID: 17092975
    [Abstract] [Full Text] [Related]

  • 30. Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease.
    von Gunten A, Bouras C, Kövari E, Giannakopoulos P, Hof PR.
    Brain Res Rev; 2006 Aug 12; 51(2):176-211. PubMed ID: 16413610
    [Abstract] [Full Text] [Related]

  • 31. A chronic Alzheimer's model evoked by mitochondrial poison sodium azide for pharmacological investigations.
    Szabados T, Dul C, Majtényi K, Hargitai J, Pénzes Z, Urbanics R.
    Behav Brain Res; 2004 Sep 23; 154(1):31-40. PubMed ID: 15302108
    [Abstract] [Full Text] [Related]

  • 32. Pacific paradigms of environmentally-induced neurological disorders: clinical, epidemiological and molecular perspectives.
    Garruto RM.
    Neurotoxicology; 1991 Sep 23; 12(3):347-77. PubMed ID: 1745428
    [Abstract] [Full Text] [Related]

  • 33. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z.
    Neuroscience; 2007 Jun 15; 147(1):28-36. PubMed ID: 17499931
    [Abstract] [Full Text] [Related]

  • 34. Assessing cognitive function after intracerebral hemorrhage in rats.
    MacLellan CL, Langdon KD, Churchill KP, Granter-Button S, Corbett D.
    Behav Brain Res; 2009 Mar 17; 198(2):321-8. PubMed ID: 19041895
    [Abstract] [Full Text] [Related]

  • 35. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease.
    Lovasic L, Bauschke H, Janus C.
    Genes Brain Behav; 2005 Apr 17; 4(3):197-208. PubMed ID: 15810906
    [Abstract] [Full Text] [Related]

  • 36. Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: a comparative study.
    Seltzer B, Vasterling JJ, Mathias CW, Brennan A.
    Neuropsychiatry Neuropsychol Behav Neurol; 2001 Apr 17; 14(2):122-9. PubMed ID: 11417666
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Reasons for holding a Consensus Conference on neuropsychological rehabilitation in adult patients.
    Làdavass E, Paolucci S, Umiltà C.
    Eur J Phys Rehabil Med; 2011 Mar 17; 47(1):91-9. PubMed ID: 21448122
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.